Session finder
(perliminary, v. 21.08.2015)
Download the abstractbook here (high resolution, 58 mb). Or with a low resolution here (5 mb).
| Session | Theme | 20 Sept. | 21 Sept. | 22 Sept. | 23 Sept. | ||||||||
| 13:45 - 15:15 |
16:00 - 17:30 |
09:00 - 10:30 |
11:00 - 12:30 |
13:30 - 15:00 |
15:30 - 17:00 |
09:00 - 10:30 |
11:00 - 12:30 |
13:30 - 15:00 |
15:30 - 17:00 |
09:00 - 10:30 |
11:30 - 12:30 |
||
| 1.1 | Multi-Organ-Chip I |
detail | |||||||||||
| 1.2 | Multi-Organ-Chip II |
detail | |||||||||||
| 2 | Stem Cells | detail | |||||||||||
| 3.1 | 3D Models I |
detail | |||||||||||
| 3.2 | 3D Models II |
detail | |||||||||||
| 4 | 3R International | detail | |||||||||||
| 5.1 | QSAR & Read Across I |
detail | |||||||||||
| 5.2 | QSAR & Read Across II |
detail | |||||||||||
| 6 | Risk Ass. & AOP | detail | |||||||||||
| 7 | Rep. Dose & Other Endpoints | detail | |||||||||||
| 8 | Inhalation | detail | |||||||||||
| 9.1 | Skin Sensitization I |
detail | |||||||||||
| 9.2 | Skin Sensitization II |
detail | |||||||||||
| 10.1 | Efficacy & Safety Testing I |
detail | |||||||||||
| 10.2 | Efficacy & Safety Testing II |
detail | |||||||||||
| 11 | Nano-Toxicology | detail | |||||||||||
| 12.1 | Disease Models I: CRISPR/cas | detail | |||||||||||
| 12.2 | Disease Models II: hiPSC | detail | |||||||||||
| 12.3 | Disease Models III: Inflammation | detail | |||||||||||
| 13 | Biobarriers | detail | |||||||||||
| 14 | Directive 2010/63/EU | detail |
|||||||||||
| 15.1 | Ethics & Legal Issues I |
detail | |||||||||||
| 15.2 | Ethics & Legal Issues II |
detail | |||||||||||
| 16.1 | Refinement I and Culture of Care |
detail | |||||||||||
| 16.2 | Refinement II |
detail | |||||||||||
| 17.1 | Replacement I |
detail | |||||||||||
| 17.2 | Replacement II |
detail | |||||||||||
| 18.1 | 3Rs in Academia & Education I |
detail | |||||||||||
| 18.2 | 3Rs in Academia & Education II |
detail | |||||||||||
| 19.1 | Young Scientists Short Lectures I |
detail | |||||||||||
| 19.2 | Young Scientists Short Lectures II |
detail | |||||||||||
Download the session finder as pdf HERE
paid advertising
|
paid advertising
|
